Athyrium Capital Management, LP's most recent trades

10% Owner

%

COMPANY

SHARES

NET TOTAL

90.03%

Amryt Pharma PLC

8,857,268

$61,912,000.00

7.43%

PUMA BIOTECHNOLOGY INC

1,792,114

$5,108,000.00

2.55%

Societal CDMO Inc.

2,202,420

$1,751,000.00